Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)

This study has been completed.
Information provided by:
Eyetech Pharmaceuticals Identifier:
First received: July 13, 2004
Last updated: May 2, 2006
Last verified: May 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given